GENERAL INFORMATION
Established:  1996
Type:  Graduated from Technological Incubator
Ownership:  Private

Core business

Microspheres for medicine and biotechnology; Treatment for wound
healing.

Employees:  7
Professionals:  5

Overview

POLYHEAL relies on an innovative patented microsphere based
method for the stimulation of wound healing and tissue
regeneration.ÿActivation of the cells involved in the healing
process provides an effective technique for dealing with healing
and regeneration problems resulting from chronic ulcers, trauma,
injuries, bedsores, burns and surgery.

Preliminary clinical trials were conducted using standard
clinical trial conditions. All patients involved in the trial
received the best available standard treatment before the trial.
The patients who were treated for chronic ulcers had primary
diagnoses that included NIIDM, Breast Cancer IIB, Bechet Disease,
chronic drug dependence +DM, Rheumatoid Arthritis, Vascular
Surgery, etc. Detailed analysis of this trial is not yet
completed.

Clinical Benefits
Physicians who have tested POLYHEAL treatment are impressed with
the results.ÿMajor medical and pharmaceutical firms familiar with
POLYHEAL have expressed a preliminary interest in conducting
detailed clinical testing. Israel's well-deserved reputation for
advances in medicine, science, technology and engineering
promotes POLYHEAL's acceptance.ÿIn preliminary tests and trials a
large number advantages over existing treatments have become
apparent:
* Meaningful reduction in the time required for healing;
* Reduction in the prominence and size of scars;
* Reduced pain from the wound;
* Absence of immunological problems;
* Non allergenic;
* Clear anesthetic effect;
* Non-toxic;
* No side effects.